Key statistics
As of last trade Aurinia Pharmaceuticals Inc (IKAP:STU) traded at 11.85, -16.55% below its 52-week high of 14.20, set on Nov 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.66 |
|---|---|
| High | 11.90 |
| Low | 11.50 |
| Bid | 11.95 |
| Offer | 12.04 |
| Previous close | 11.79 |
| Average volume | 113.43 |
|---|---|
| Shares outstanding | 132.97m |
| Free float | 122.85m |
| P/E (TTM) | 25.26 |
| Market cap | 1.88bn USD |
| EPS (TTM) | 0.561 USD |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
- Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
- Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
